On March 2, 2022 SCYNEXIS, Inc. (NASDAQ: SCYX), a biotechnology company pioneering innovative medicines to overcome and prevent difficult-to-treat and drug-resistant infections, reported its participation in three in-person medical conferences and one virtual investor panel in March (Press release, Scynexis, MAR 2, 2022, View Source [SID1234609356]). Marco Taglietti, M.D., President and Chief Executive Officer of SCYNEXIS, will participate in a live panel discussion on drug development in Women’s Health. Event details can be found below:

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Conferences:

International Society for the Study of Women’s Sexual Health (ISSWSH)
Date: March 3-6, 2022
Location: Dallas
Event Page
Council on Resident Education in Obstetrics and Gynecology (CREOG) & Association of Professors of Gynecology and Obstetrics (APGO) Annual Meeting
Date: March 9-12, 2022
Location: Orlando
Event Page
Academy of Managed Care Pharmacy (AMCP)
Date: March 29- April 1, 2022
Location: Chicago
Event Page
Virtual Investor Panel:

Maxim Group’s Annual Growth Conference
Panel: Women’s Health Virtual Event
Date: March 28, 2022
Location: Virtual
Time: 3:00 p.m. ET
Event Page